GeneriCo, LLC Completes Transaction
17 juil. 2018 09h49 HE
|
GeneriCo, LLC
ST. LOUIS, July 17, 2018 (GLOBE NEWSWIRE) -- GeneriCo, LLC (GeneriCo), a specialty generic drug company, today announced that it completed a deal transaction with a leading US generic pharmaceutical...
GeneriCo, LLC Prevails in Inter Partes Review of United States Patent 8,865,688
19 mai 2017 16h35 HE
|
GeneriCo, LLC
ST. LOUIS, May 19, 2017 (GLOBE NEWSWIRE) -- GeneriCo, LLC (GeneriCo), a global specialty generic drug company, today announced that the Patent Trial and Appeal Board (“PTAB”) of the U.S. Patent and...
Pharmaceuticals Veteran George R. Stevenson Joins the GeneriCo Board of Directors
27 janv. 2017 11h29 HE
|
GeneriCo, LLC
ST. LOUIS, Jan. 27, 2017 (GLOBE NEWSWIRE) -- GeneriCo, LLC (“GeneriCo”), a global generic specialty pharmaceutical company, is pleased to announce that George R. Stevenson has joined the Company’s...
GeneriCo Announces Collaboration with Zhejiang Hisun to Launch Generic Pharmaceutical Products in the US
08 sept. 2016 22h30 HE
|
GeneriCo, LLC
ST. LOUIS, Sept. 08, 2016 (GLOBE NEWSWIRE) -- GeneriCo, LLC, a global specialty generic pharmaceutical company, has announced the signing of a collaboration with Zhejiang Hisun Pharmaceutical Co,...
GeneriCo, LLC Inter Partes Review of United States Patent 8,865,688 Instituted
13 juin 2016 09h00 HE
|
GeneriCo, LLC
ST. LOUIS, June 13, 2016 (GLOBE NEWSWIRE) -- GeneriCo, LLC (“GeneriCo”), a global specialty generic drug company, today announced it has received a favorable institution decision for its petition...
GeneriCo, LLC Files for Inter Partes Review of United States Patent 8,865,688
15 déc. 2015 20h41 HE
|
GeneriCo, LLC
ST. LOUIS, Dec. 15, 2015 (GLOBE NEWSWIRE) -- GeneriCo, LLC (“GeneriCo”) today announced that it has recently filed a petition for Inter Partes Review (“IPR”) of United States Patent No. 8,865,688...